Reliable biomarkers for early detection of hepatocellular carcinoma (HCC) in patients with cirrhosis are lacking. We evaluated the use of miR-122, alpha-fetoprotein (AFP) and protein induced by vitamin k absence/antagonist II (PIVKA-II) for HCC risk prediction in patients with HBV-related cirrhosis under surveillance.

Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II

Caviglia, Gian P;Abate, Maria L;Olivero, Antonella;Rosso, Chiara;Ciancio, Alessia;Saracco, Giorgio M;Smedile, Antonina
2017

Abstract

Reliable biomarkers for early detection of hepatocellular carcinoma (HCC) in patients with cirrhosis are lacking. We evaluated the use of miR-122, alpha-fetoprotein (AFP) and protein induced by vitamin k absence/antagonist II (PIVKA-II) for HCC risk prediction in patients with HBV-related cirrhosis under surveillance.
59
4
283
289
Caviglia, GIAN PAOLO; Abate, Maria Lorena; Gaia, Silvia; Petrini, Elisa; Bosco, Caterina; Olivero, Antonella; Rosso, Chiara; Ciancio, Alessia; Pellicano, Rinaldo; Saracco, Giorgio Maria; Rizzetto, Mario; Smedile, Antonina
File in questo prodotto:
File Dimensione Formato  
Paper_HCC Biomarkers_IRIS.doc

Accesso riservato

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 255 kB
Formato Microsoft Word
255 kB Microsoft Word   Visualizza/Apri   Richiedi una copia
Paper_HCC Biomarkers_IRIS.pdf

Accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 228.2 kB
Formato Adobe PDF
228.2 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/1652359
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 33
social impact